I am writing today to announce the closure of the New Mexico Independent. After three and a half years of operation in New Mexico, the board of the American Independent News Network, has decided to shift publication of its news…
While environmental activists played their part yesterday during demonstrations at the capitol building, going so far as to dress up as solar panels and to sing the tune of “You Are My Sunshine,” their counterparts, the anti-cap-and-trade contingency who has…
Roughly one quarter of University of New Mexico students are unimpressed with the state’s flagship public school, according to a survey that questioned college students about their higher education experiences.
The Food and Drug Administration under President Bush valued politics over science, a District Court said last year in ordering the agency to approve the morning-after pill for women 17 and older. The court also ordered the FDA to reconsider approving the drug for women of all ages, but now one group says President Obama’s administration is stalling on a promise to expand access to the drug and allow it to be sold to those under 18.
The Center for Reproductive Rights is taking the FDA back to court for its failure to respond to a court order about the expansion.
Although the drug is similar to birth control pills, some pro-life groups have opposed the morning-after pill on moral grounds. The drug is classified as birth control and has not be shown to cause harm to a pregnancy.
“The FDA has had ample time, countless opportunities, and overwhelming scientific evidence put before it to make a decision on Plan B,” said Nancy Northup, president of the Center for Reproductive Rights. “The President promised that his administration would reverse the Bush policy of politics trumping science. But when it comes to emergency contraception, it’s a new administration playing the same old games.”
“All of the scientific facts are there and FDA experts agree – emergency contraception has proven safe and effective to be sold over-the-counter to all ages,” said Suzanne Novak, lead counsel in the case. ”It’s time for the FDA to stop the stonewalling, follow the science, and make emergency contraception available without a prescription to women of all ages.”
